Overview
Three-dimensional (3D) bioprinting is a revolutionary additive manufacturing process that leverages principles akin to traditional 3D printing to construct complex biological structures. It involves the precise deposition of living cells, biomaterials, and signaling molecules, known collectively as bio-inks, in a layer-by-layer fashion. The primary goal is to create functional, three-dimensional tissues and organs for a myriad of applications, ranging from regenerative medicine and drug discovery to biosensing and environmental remediation. While early efforts focused on tissue engineering, the field has expanded dramatically, with researchers now aiming to replicate the intricate architecture and cellular density required for fully functional organs. Despite significant advancements, the clinical translation of bioprinted constructs remains a formidable challenge, necessitating further innovation in bio-ink formulation, printing resolution, and long-term cell viability, as highlighted by ongoing research at institutions like the [[wake-forest-institute-for-regenerative-medicine|Wake Forest Institute for Regenerative Medicine]].